CFR›Title 21›Chapter I›Part 201›Subpart F ContainsSection 201.200CorpusDaily eCFRDisplayed edition2026-05-13Last updated2026-05-13 Subpart F—Labeling Claims for Drugs in Drug Efficacy Study Sections 201.200 § 201.200 Disclosure of drug efficacy study evaluations in labeling and advertising. Previous E Subpart E—Other Exemptions Next G Subpart G—Specific Labeling Requirements for Specific Drug Products